Table 2. In Vivo Rat PK Properties after Dosing of 3 mg/kg IV and 10 mg/kg PO.
rat PKa | 15b | 16b | 17c |
---|---|---|---|
CL (mL/min/kg) | 56.9 | 45.5 | 45.2 |
Vss (L/kg) | 2.3 | 2.4 | 4.9 |
T1/2 (h) | 0.83 | 0.9 | 1.6 |
AUC PO (h·nM) | 659 | 1897 | 1879 |
Cmax PO (nM) | 110 | 250 | 215 |
F(%) PO | 10 | 26 | 27 |
Route: Intravenous (3 mg/kg) and oral administrations (10 mg/kg). Formulation as a solution in 75% PEG300/25% D5W.
Male Sprague–Dawley rat.
Male Wistar rat.